Helena Biosciences is a leading medical diagnostic company with an international reputation comprising two flagship business divisions that specialise in the design, manufacture and support of Clinical Electrophoresis and Haemostasis systems.

Proudly manufacturing in Great Britain, with commercial and plant facilities based in the North East of England, Helena Biosciences has achieved its status as a market leader due to a commitment to quality and innovation, and the dedication to customers and partners through continual training and technical support.

For over three decades, the company has been a market leader in clinical electrophoresis technology, pioneering advances in the design of instrumentation, applications and software for acetate, agarose and since 2009 — fully automated Clinical Capillary Electrophoresis (CCE).

On the back of prolific business demand for this product and pioneering transformations in system automation— including FDA registration, Helena Bioscience’s new V8 E-Class CCE system, launched in December 2012, is a second generation analyser and the perfect partner to Helena’s superior agarose gel portfolio.

Flagship business divisions

Clinical Electrophoresis

Manual and semi-automated gel electrophoresis
Automated capillary electrophoresis
Extensive protein analysis portfolio
Haemoglobin testing (HbA₂; F, S, C, D, E etc.)
CDT testing for clinical and forensic aims

Haemostasis Solutions

Routine assays (e.g. PT, TT, aPTT, Fib)
Specialist assays (e.g. Protein S, Protein C, D-Dimer)
Platelet Function assays
Integrated instrumentation
Product distribution
OEM agreements

Helena Biosciences - Model V8 Nexus -Next-generation Analyser

Details